... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
Medicine Products:(Date:10/10/2008)...LE, PA The American Nurses Credentialing Center (...) as a Magnet hospital. The news came via a confer...taff who broke out with cheers and applause., GMC...itals and only 294 hospitals in the United States... hospitals are eligible for this recognition., "A...
(Date:10/10/2008)...ggests poor self-care partly to blame , ,...f Medicare beneficiaries who have diabetes, being ... according to a new study. , Publishing in th...l Medicine , researchers from the University of Wa...erage age of 75.6 years) who had diabetes and were...
(Date:10/10/2008)... Honoring excellence in the imple... Healthcare Information and Management Systems Soc...Davies Awards in the Organizational, Ambulatory an... Chicago, IL (PRWEB) October 1...on of electronic health records (EHRs), the Healt...
(Date:10/10/2008)...YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins Un...ultimedia educational program,"Optimizing Adjuvan...atment,Selection," to present recent key research ...ment., In recent years, advancements in the treat... and biologic treatment combinations that are,incr...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2(Date:10/7/2008)... Showed Larazotide Acetate Prevented Immunologic C...ts with Celiac Disease, Additional Data Indicates ... ORLANDO, Fla., Oct. 7 /- Alba Therap...ical studies this week at the American,College of ...ing. Data from,study CLIN 1001-004, the first Phas...
(Date:10/7/2008)...a clinical study of adults, VYVANSE taken once-dai...hin one week, PHILADELPHIA, Oct. 7 /PRNewswire-Fi...he global specialty biopharmaceutical company, tod...er issue of the Journal of,Clinical Psychiatry fou...tion Deficit Hyperactivity Disorder (ADHD) symptom...
(Date:10/7/2008)... - Data Presented Today at ACG Annual Scientific ...tCall/ -- Ironwood,Pharmaceuticals, Inc. (formerly...SE: FRX ) today announced the presentation of res... safety and efficacy in 420 patients with,irritabl...is of the data,indicates that once- daily oral dos...
(Date:10/7/2008)...KELEY, Calif., Oct. 7 /- Aerovance In...data from a Phase I trial of its Aerovant,inhalati...no evidence of,local irritancy following asthma pa...10 mg dose will be the highest of three doses inve...dy, which is scheduled to begin early,next year. E...
Breaking Medicine Technology:Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 5Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 6Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5Data Show Aerovance's Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients 2Simons Foundation awards Emory scientists 243M for autism gene research 674 1Simons Foundation awards Emory scientists 243M for autism gene research 674 2DURECT to Present at 2007 BIO Investor Forum 2871 1AspenBio Pharma to Present the Edgewater Research Investor Conference 1060 1AspenBio Pharma to Present the Edgewater Research Investor Conference 1060 2The Food Allergy 26 Anaphylaxis Network 28FAAN 29 and Verus Pharmaceuticals Work Together to Raise Awareness of Food Allergies 1056 1The Food Allergy 26 Anaphylaxis Network 28FAAN 29 and Verus Pharmaceuticals Work Together to Raise Awareness of Food Allergies 1056 2The Food Allergy 26 Anaphylaxis Network 28FAAN 29 and Verus Pharmaceuticals Work Together to Raise Awareness of Food Allergies 1056 3The Food Allergy 26 Anaphylaxis Network 28FAAN 29 and Verus Pharmaceuticals Work Together to Raise Awareness of Food Allergies 1056 4...Show Potential of microRNAs as,Novel Cancer Drug T...ersey, July 05, 2007,/PRNewswire-FirstCall/ -- Ros...nounced today research published in the journal,Mo...tute of Science,and Rosetta Genomics . The finding...roRNA (miR-34a) to be used as a drug candidate,in ...
...INATE, Italy - July 4, 2007 - Cosmo Pharmaceutical...ary results from its,phase II/III study with CB-01.... CB-01-11 is a broad spectrum, semi-synthetic,ant...form. Through,the use of Cosmo,s MMX(tm) technolog...olon, bacteria in the gastro intestinal tract,that...
Other Medicine Technology:Rosetta Genomics and Weizmann Institute Scientists Identify Role of,microRNA in Cancer Suppression 2Rosetta Genomics and Weizmann Institute Scientists Identify Role of,microRNA in Cancer Suppression 3Rosetta Genomics and Weizmann Institute Scientists Identify Role of,microRNA in Cancer Suppression 4Rosetta Genomics and Weizmann Institute Scientists Identify Role of,microRNA in Cancer Suppression 5Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III,Data with Rifamycin MMX in Infectious Diarrhea 2